Study of the safety and efficacy of tolvaptan for fluid retention symptoms of right heart failure due to pulmonary hypertensio
Not Applicable
- Conditions
- pulmonary hypertension
- Registration Number
- JPRN-UMIN000010196
- Lead Sponsor
- Department of Cardiology, Keio University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1) Systolic blood pressure is less than or equal to 70mmHg 2) There is a history of hypersensitivity for similar compounds (such as hydrochloride Mozabaputan) components or tolvaptan 3) Anuria 4) A subject is difficult to feel thirst or water intake 5) Hypernatremia 6) There is a possibility that a subject is pregnant or pregnant women 7) Hepatic coma 8) There is a history of hypersensitivity to sulfonamide derivatives 9) Tolvaptan has been administered from admission to registration 10) Acute coronary syndromes 11) Scheduled to perform coronary angioplasty during follow-up period 12) Physicians and other staff have been deemed inappropriate for registration of this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method